Enlivex Therapeutics Ltd. buy Liberte
Start price
03.10.20
/
50%
€11.30
Target price
04.11.21
-
Performance (%)
-43.36%
End price
20.07.21
€6.40
Summary
This prediction ended on 20.07.21 with a price of €6.40. Massive losses of -43.36% were the result for the BUY prediction by Liberte. Liberte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Enlivex Therapeutics Ltd. | -9.392% | -9.392% | 32.258% | -29.915% |
| iShares Core DAX® | 0,18 % | 5,07 % | 8,98 % | 63,88 % |
| iShares Nasdaq 100 | -0,77 % | -2,08 % | 26,44 % | 88,09 % |
| iShares Nikkei 225® | 0,73 % | -3,35 % | 47,89 % | 78,01 % |
| iShares S&P 500 | -0,17 % | 0,90 % | 22,97 % | 69,45 % |
According to Liberte what are the pros and cons of Enlivex Therapeutics Ltd. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Liberte for this prediction
In the thread Enlivex Therapeutics Ltd. diskutieren
Buy Bio Blast Pharma Ltd